weight-loss.ca

Mounjaro Review (2026): Does It Work for Weight Loss in Canada?

Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist manufactured by Eli Lilly that has gained significant attention in Canada for weight loss. Originally approved for type 2 diabetes, it's now recognized as a powerful weight management tool. This review examines its effectiveness, cost, availability in Canada, side effects, and whether it's the right choice for your weight loss journey.

8.0
✓ RecommendedOverall: 8/10

Mounjaro is a potent GIP/GLP-1 receptor agonist with strong clinical evidence for weight loss, approved by Health Canada for diabetes and weight management. It's effective but expensive, requires ongo

Best for

Adults with obesity or overweight (BMI ≥27) with type 2 diabetes or metabolic risk factors, who have failed other weight loss methods and can afford ongoing costs.

Not for

Pregnant or breastfeeding individuals, those with personal/family history of medullary thyroid cancer, people unable to afford long-term treatment, or those unable to tolerate injectable medications.

Key Facts

TypeGIP/GLP-1 receptor agonist injection
ManufacturerEli Lilly
Health Canada StatusApproved by Health Canada for type 2 diabetes management and weight management in adults with obesity or overweight
Price (CAD)$300-450 per month (varies by pharmacy and dose); may be partially covered under provincial drug plans
Prescription RequiredYes
Where to Buylicensed pharmacy with prescription, specialty diabetes clinics

Ratings Breakdown

Effectiveness for Weight Loss8.5/10

Clinical trials show average weight loss of 15-22% of body weight over 68 weeks; superior to GLP-1 only agents like semaglutide

Ease of Use7/10

Once-weekly subcutaneous injection; requires consistent adherence and self-injection or clinic visits

Safety Profile7.5/10

Generally well-tolerated; common side effects are gastrointestinal; serious adverse events are rare but require medical monitoring

Affordability in Canada6/10

Expensive at $300-450/month; coverage varies significantly by province; out-of-pocket costs may be prohibitive for many Canadians

Accessibility6.5/10

Requires prescription and ongoing medical supervision; supply constraints have eased but availability varies by region

Long-term Sustainability7.5/10

Weight regain occurs after discontinuation; requires indefinite use for sustained benefit; lifestyle changes still essential

Pros & Cons

Pros

  • ✓Clinically proven significant weight loss (15-22% body weight reduction in trials)
  • ✓Improves cardiovascular outcomes and metabolic health markers beyond weight loss alone
  • ✓Once-weekly injection is convenient compared to daily oral medications
  • ✓Dual mechanism (GIP+GLP-1) more effective than single-agent GLP-1 drugs like Ozempic
  • ✓Health Canada approved for both diabetes and weight management indications

Cons

  • ✗High monthly cost ($300-450) with inconsistent provincial drug coverage; unaffordable for many Canadians
  • ✗Gastrointestinal side effects (nausea, vomiting, diarrhea) common, especially at higher doses
  • ✗Requires ongoing injections indefinitely; weight regain occurs after stopping
  • ✗Must be combined with lifestyle changes; medication alone insufficient for sustained results
  • ✗Supply constraints have eased but availability still variable across Canadian provinces

How It Works

Mounjaro activates two hormone receptors—GIP and GLP-1—that regulate appetite, blood sugar, and metabolism. It slows gastric emptying (making you feel full longer), reduces hunger signals from the brain, and improves how your body uses glucose. This dual action makes it more potent than medications that target only GLP-1.

What the Evidence Says

The SURMOUNT clinical trials (published 2022-2023) demonstrated that tirzepatide produces weight loss of 15-22% over 68 weeks, with cardiovascular benefits including reduced blood pressure and improved cholesterol. A 2024 meta-analysis in The Lancet confirmed superiority over GLP-1 monotherapy. Real-world Canadian data is limited, but international evidence supports efficacy in diverse populations. Long-term data beyond 2 years remains incomplete.

Side Effects

Who Should Consider This

Adults with BMI ≥27 kg/m² (or ≥25 with weight-related conditions) who have tried lifestyle modifications, have type 2 diabetes or metabolic risk factors, can afford ongoing treatment, are willing to self-inject weekly, and have medical supervision available. Best results occur when combined with diet, exercise, and behavioral changes.

🍁 Canadian Availability

Mounjaro is available through licensed Canadian pharmacies with a valid prescription from a physician or nurse practitioner. Cost is $300-450/month; coverage varies: Ontario (ODB covers for diabetes, limited weight management coverage), British Columbia (PharmaCare coverage available for eligible patients), Alberta (limited coverage), and other provinces vary. Many patients access it privately or through employer health plans. Specialty diabetes clinics in major cities often stock it. Eli Lilly offers patient assistance programs for eligible Canadians with financial hardship.

How It Compares to Alternatives

Comparing GIP/GLP-1 receptor agonist injection to other weight loss options available in Canada.

1

Ozempic/Saxenda (semaglutide — GLP-1 only)

Mounjaro's dual GIP/GLP-1 action produces greater weight loss (22% vs 15%) but higher cost; semaglutide more established with longer safety data

2

Metformin (oral, first-line diabetes medication)

Much cheaper and oral, but significantly less effective for weight loss; Mounjaro superior for significant weight reduction but requires injection

3

Contrave (naltrexone/bupropion — oral combination)

Oral and lower cost, but produces only 5-10% weight loss; Mounjaro far more effective but injectable and expensive

4

Bariatric surgery (gastric bypass, sleeve gastrectomy)

One-time procedure with durable results; Mounjaro non-surgical and reversible but requires ongoing use; surgery riskier but may be more cost-effective long-term

⚠ Medical Disclaimer: This review is for informational purposes only. This is not medical advice. Consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment program.

Frequently Asked Questions

Coverage varies by province. Ontario's ODB covers it for type 2 diabetes; weight management coverage is limited. British Columbia's PharmaCare covers it for eligible patients. Alberta and other provinces have restricted coverage. Check with your province and private insurance. Many patients pay out-of-pocket or use employer benefits.

Related Articles

Ready to Explore Mounjaro for Weight Loss?

If you're considering Mounjaro, start with a consultation with your family doctor, nurse practitioner, or endocrinologist. They'll assess your health, discuss costs and coverage in your province, and determine if it's appropriate for you. Bring questions about side effects, long-term use, and how to combine it with lifestyle changes. Remember: medication works best alongside healthy eating, regular physical activity, and behavioral support.